Form banner image

Welcome to 5th Oncology Forum

Abstract Submission

Healthcare professionals from the GCC and beyond are invited to submit abstracts for Oral and E-Poster presentations at the 5th Annual International Oncology Forum (IOF 2026), taking place on 11–12 April 2026 at SHANGRI-La Dubai, UAE.
Participants are encouraged to submit original, unpublished research and clinically relevant scientific studies across a wide range of general oncology topics.
This is a unique opportunity to exchange knowledge, share best practices, and contribute to advancing cancer care through evidence-based research.

SUBMISSION CATEGORIES

  • Adrenal Cancer

  • Biliary Tract Cancer, Incl. Cholangiocarcinoma

  • Breast Cancer, Early Stage

  • Breast Cancer, Locally Advanced

  • Breast Cancer, Metastatic

  • CNS Tumours

  • Colorectal Cancer

  • Endocrine Tumours

  • Germ Cell (Testicular) Cancer

  • Gynaecological Cancers

  • Haematological Malignancies

  • Head and Neck Cancer

  • Hepatocellular Carcinoma (HCC)

  • Interventional Radiology and Oncology

  • Melanoma and Other Skin Tumours

  • Neuroendocrine Tumours

  • Small Cell Lung Cancer

  • Pharmacy and therapeutics

  • NSCLC, Metastatic

  • Oesophagogastric Cancer

  • Palliative Care

  • Pancreatic Cancer

  • Penile Cancer

  • Prostate Cancer

  • Psycho-Oncology

  • Renal Cancer

  • Sarcoma

  • Supportive Care

  • Thoracic Malignancies, Other

  • Thyroid Cancer

  • Tumour Biology And Pathology

  • Urothelial Cancer

  • Cancer Nursing

  • NSCLC, Early Stage

  • NSCLC, Locally Advanced

  • Quality improvement

KEY DATES

  • Submission of Abstracts Closes: 15th March 2026

  • Acceptance Communication: 29th March 2026

  • Final Submission of Abstract Poster: 5th April 2026

ABSTRACT AND SUBMISSION CONDITIONS

  • Abstracts must be based on original scientific research that has not been published previously.

  • Research should address clinically relevant scientific questions within the listed submission categories.

  • Accepted study types include:

    • Randomized clinical trials

    • Prospective studies

    • Retrospective research studies

  • Submissions should represent high-impact research with practice-changing implications.

  • Case reports and case series will not be accepted

ABSTRACT GUIDELINES

Abstract content must meet the following guidelines:

  • Should address clinically relevant scientific questions as per the below mentioned categories.

  • Original scientific data in the form of a randomized clinical trials or prospective or retrospective research studies that have not been published previously.

  • High-impact research with practice-changing implications.

  • Case reports will not be accepted

POST SUBMISSION

  • Deadline for Abstract Submission: 15th March 2026

  • Notification of Acceptance: Will be sent via email after the Scientific Committee reviews all abstracts.

  • Extensions: Any extension to the submission deadline, if recommended by the Scientific Committee, will be communicated through the official website, email, and social media channels.

  • Publication: All accepted abstracts will be published in a peer-reviewed journal.

  • Presentation Opportunity: Selected abstracts may be offered an opportunity for oral presentation as part of the conference agenda.

  • Modification / Withdrawal: Once submitted, abstracts cannot be modified or withdrawn.

IMPORTANT DETAILS

Abstract Content & Format

  • The abstract must include the following sections:

    • Introduction

    • Objectives

    • Materials and Methods

    • Results

    • Conclusions

  • Maximum length: 600 words

  • Abstract must be written in English

  • Provide 5–6 keywords related to the topic

  • Covering letter stating the purpose of presenting the work at IOF 2026 is required

First Author Responsibilities & Eligibility

  • The first author must present the abstract if selected

  • If unavailable, a co-author with similar eligibility criteria may present, provided:

    • The co-author is listed in the abstract

    • The organizing committee is informed at least 14 days prior to the event

  • All oral presenters must obtain a speaker permit prior to the event

First Author Eligibility Criteria

  • Must NOT be in a consultant, professor, or leadership position

  • Must NOT be in a senior nursing or leadership role

  • Trainees, medical officers, specialists, researchers, and medical students are encouraged to submit as first authors

Mentorship

  • Abstract presentations are intended to encourage junior and trainee presenters with support from senior mentors

  • Single-author submissions are discouraged

JIPO REQUIRED INSTRUCTIONS & GUIDELINES FOR APPROVED E-POSTER PRESENTATIONS

  • FORMAT: All abstracts must be prepared and submitted according to the following guidelines:

  • LENGTH: Maximum 600 words including title, author information, and text.

  • AUTHORS: Include the full name of each author in the desired order. Use superscript numbers to indicate each author’s affiliation. Do not include professional titles or degrees.

  • Important: The submitting author should not add other co-authors without their prior agreement. Do not include anyone who does not meet the criteria for authorship as defined by the ICMJE.

  • AFFILIATIONS: Number each affiliation and include department (if applicable), institution or company name, city, state (if applicable), and country.

  • EMAIL: The submitting author must provide a valid email address for queries

  • STRUCTURE: Abstracts should have headings: Introduction, Methods, Results, Conclusion

    • Case reports and series will not be accepted

    • Text must be in English, define abbreviations at first mention, avoid references

    • TABLES/FIGURES: 1–2 brief tables or figures (high resolution, 300 dpi) allowed; may be removed if needed due to space constraints

    • PROOFREAD: Abstracts will be published as-is

  • RESPONSIBILITY: All authors approve the final version and agree to be accountable for all aspects of the work

  • PERMISSION TO PUBLISH: Submission grants permission for JIPO publication

  • COPYRIGHTS: Abstract must not include copyrighted material and must not be under consideration elsewhere

  • QUESTIONS: Contact [email protected]

Restrictions:

  • Do not include audio/video files

  • Do not include hyperlinks (no internet on e-poster screens)

TERMS OF ACCEPTANCE

  • Authors are fully responsible for spelling, grammar, and scientific accuracy

  • Abstracts will be published exactly as submitted; no proofreading will be performed

  • All authors must approve the final version and agree to be accountable for all aspects of the work

  • Abstracts must:

    • Not include copyrighted material

    • Not be submitted elsewhere or under consideration by another conference

    • Be embargoed until the date of presentation or publication

  • Authors must be available for discussion during the corresponding poster viewing session

Contact Details

Country

Abstract Details

Your abstract should provide a concise overview of your research, including the objective, methodology, key findings, and conclusion. The content must be clear, well-structured, and written in English.

Type in ALL UPPERCASE LETTERS. Abstract Title can no longer be 100 words.
Please list a maximum of five (5) co-authors involved in the abstract.
Poster presentations, the abstract text must not exceed 3,000 characters. Oral presentations should be no longer than 10–15 minutes. Please ensure the abstract is uploaded in PDF format only.